Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction-Reference-Cited by-同舟云学术

Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction

Published:2006-02 Issue:2 Volume:239 Page:113-120
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Cooper David,Mester Joseph C.,Guo Min,Nasar Farooq,Souza Victor,Dispoto Sharon,Sidhu Maninder,Hagen Michael,Eldridge John H.,Natuk Robert J.,Pride Michael W.

Publisher

Elsevier BV

Subject

Immunology

Reference31 articles.

1. Challenges in genital herpes simplex virus management;Corey;J. Infect. Dis.,2002

2. Recent progress in herpes simplex virus immunobiology and vaccine research;Koelle;Clin. Microbiol. Rev.,2003

3. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration;Highlander;J. Virol.,1987

4. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface;Fuller;Proc. Natl. Acad. Sci. USA,1987

5. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group;Corey;JAMA,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herpes Simplex Virus 1 and 2 Vaccine Design: What can we Learn from the Past?;Herpesviridae;2016-09-07

2. A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma;The Journal of Immunology;2015-09-16

3. Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses;Clinical and Experimental Immunology;2011-12-01

4. Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice;Journal of Virology;2011-03-09

5. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein;Vaccine;2010-03